Australia markets close in 1 hour 26 minutes

Fuji Pharma Co., Ltd. (FUP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
8.40-0.45 (-5.08%)
At close: 08:06AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 217.29M
Enterprise value 369.97M
Trailing P/E 6.17
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.85
Price/book (mrq)0.83
Enterprise value/revenue 1.46
Enterprise value/EBITDA 5.52

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 310.63%
S&P500 52-week change 327.84%
52-week high 312.60
52-week low 36.65
50-day moving average 39.51
200-day moving average 39.28

Share statistics

Avg vol (3-month) 313
Avg vol (10-day) 3N/A
Shares outstanding 524.31M
Implied shares outstanding 624.55M
Float 812.22M
% held by insiders 148.69%
% held by institutions 111.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.28
Forward annual dividend yield 43.16%
Trailing annual dividend rate 320.00
Trailing annual dividend yield 3225.99%
5-year average dividend yield 42.75
Payout ratio 416.42%
Dividend date 3N/A
Ex-dividend date 427 Sept 2024
Last split factor 22:1
Last split date 327 June 2018

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.75%
Operating margin (ttm)14.88%

Management effectiveness

Return on assets (ttm)2.56%
Return on equity (ttm)14.01%

Income statement

Revenue (ttm)43.05B
Revenue per share (ttm)1,771.26
Quarterly revenue growth (yoy)15.30%
Gross profit (ttm)N/A
EBITDA 6.76B
Net income avi to common (ttm)5.92B
Diluted EPS (ttm)1.43
Quarterly earnings growth (yoy)130.70%

Balance sheet

Total cash (mrq)1.38B
Total cash per share (mrq)56.56
Total debt (mrq)27.31B
Total debt/equity (mrq)61.97%
Current ratio (mrq)1.24
Book value per share (mrq)1,812.43

Cash flow statement

Operating cash flow (ttm)-44M
Levered free cash flow (ttm)-5.26B